CNP-106 Clinical Trial Myasthenia Gravis
PURPOSE
The main aim of this study is to see how safe and tolerable CNP-106, an investigational drug, is for people with Myasthenia Gravis. The study will help determine if CNP-106 can help improve your MG symptoms by reprogramming your immune system. All participants will receive CNP-106 or Placebo intravenously on Day 1, Day 8, and for some Day 90.
Key Inclusion Requirements
- Men and Women ages 18-75 years old
- Positive test for antibodies to acetylcholine receptors
- Myasthenia Gravis Foundation of America Clinical Classification Class III-IV
Key Exclusion Requirements
- Myasthenia Gravis Foundation of America Clinical Classification Class I or Class V
- If you have received a COVID-19 vaccine within 14 days of screening or are planning to receive any vaccination during your time on the study
Active Clinical Sites
Barrow Neurological Institute
Phoenix, AZ
Contact: Katherine Podsiadlo
Email: katherine.podsiadlo@dignityhealth.org
Infusion for Health
Brea, CA
Contact: Danielle Mendoza
Phone: (1) 626-536-8974
Email: damendoza@infusionforhealth.com
University of California, Irvine
Orange, CA
Contact: Dana Tran
Phone: (1) 714-509-2117
Email: danat2@hs.uci.edu
Yale University
New Haven, CT
Contact: Katerina Palma
Phone: (1) 612-594-4080
Email: katerina.palma@yale.edu
Atlantis Clinical Research
Miami, FL
Contact: Laritza Lincheta Enriquez
Phone: (1) 786-536-7779
Email: llincheta@atlantisclinicalresearch.com
Quantix Research
Miami, FL
Contact: Ryan Vespe
Phone: (1) 305-230-7371
Email: ryan.vespe@quantixresearch.com
University of South Florida
Tampa, FL
Contact: Alexis Flores
Phone: (1) 813-974-9752
Email: aflores11@usf.edu
Insight Research Institute Chicago
Chicago, IL
Contact: Ibrahim Mahgoub
Phone: (1) 312-567-6675
Email: Ibrahim.mahgoub@iinn.com
University of Kansas Medical Center
Kansas City, KS
Contact: Abby Davis
Phone: (1) 913-945-9934
Email: adavis54@kumc.edu
Insight Research Institute Dearborne
Dearborn, MI
Contact: Albaraa Alkilani
Phone: (1) 810-275-1964
Email: albaraa.alkilani@iinn.com
University of Missouri
Columbia, MO
Contact: Neetha Gali
Phone: (1) 573-882-3065
Email: ngdcd@health.missouri.edu
Ohio State University Wexner Medical Center
Columbus, HO
Contact: Karim Kheniser
Email: Karim.Kheniser@osumc.edu
Medical University of South Carolina
Charleston, SC
Contact: Alison Vance Line
Phone: (1) 843-792-2845
Email: line@musc.edu
Nerve and Muscle Center of Texas
Houston, TX
Contact: Amy Megerle
Phone: (1) 713-795-0033 ext. 14
Email: houneuamy@msn.com
Prolato Clinical Research
Houston, TX
Contact: Romeo Parada
Phone: (1) 832-338-9118
Email: rparada@prolato.org
Virginia Commonwealth University
Richmond, VA
Contact: Taylor Parkinson
Phone: (1) 804-832-1390
Email: taylor.parkinson@vcuhealth.org
Clinicaltrials.gov
Clinical Trial Identifier
A Clinical Trial Identifier is a unique number assigned to a clinical trial by clinical trial registries around the world.